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Quiescin sulfhydryl oxidase (QSOX) catalyzes formation of disulﬁde bonds between cysteine resi-
dues in substrate proteins. Human QSOX1 is a multi-domain, monomeric enzyme containing a mod-
ule related to the single-domain sulfhydryl oxidases of the Erv family. A partial QSOX1 crystal
structure reveals a single-chain pseudo-dimer mimicking the quaternary structure of Erv enzymes.
However, one pseudo-dimer ‘‘subunit” has lost its cofactor and catalytic activity. In QSOX evolution,
a further concatenation to a member of the protein disulﬁde isomerase family resulted in an
enzyme capable of both disulﬁde formation and efﬁcient transfer to substrate proteins.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Disulﬁde bond formation in proteins that enter the endoplasmic
reticulum (ER) is catalyzed by the sulfhydryl oxidase Endoplasmic
reticulum oxidoreductin 1 (Ero1) and the dithiol/disulﬁde oxidore-
ductase protein disulﬁde isomerase (PDI), both highly conserved
from yeast to humans [1–3]. In metazoans, plants, and certain pro-
tists, however, secretory proteins may encounter another sulfhy-
dryl oxidase downstream of Ero1. This additional catalyst of
disulﬁde formation is known as Quiescin Sulfhydryl OXidase
(QSOX) because its transcript levels increase as cultured cells reach
conﬂuence and enter a quiescent state [4,5]. Interest in QSOX is
intensifying, due in part to its abnormal expression in pancreatic
[6], prostate [7], and perhaps other cancers.
Although a deﬁnitive biological role and substrate set have yet
to be described for QSOX, much is known about mammalian QSOX
localization on the cellular and tissue levels. QSOX is found pre-
dominantly in the Golgi, in secretory granules, and secreted from
cells [8–10], though it has also been detected in the endoplasmic
reticulum [8]. QSOX is expressed most strongly in cell types with
high secretory loads in the immune, neural, reproductive, respira-
tory, and digestive systems, as well as in the skin and retina (re-chemical Societies. Published by E
ass).viewed in [11]). The presence of QSOX later in the secretory
pathway than Ero1 suggests that its primary role may be to
cross-link higher order assemblies of structural proteins, such as
those of the extracellular matrix, rather than to introduce disul-
ﬁdes into individual proteins early in oxidative folding. However,
the list of possible QSOX targets remains hypothetical [12].
Based on amino acid sequence analyses [5] and protein dissec-
tion [13], QSOX was found to be a fusion of two functional modules
(Fig. 1). At the amino terminus, QSOX contains a dithiol/disulﬁde
oxidoreductase module related to PDI. Toward its carboxy-termi-
nus QSOX has a sulfhydryl oxidase module, which forms disulﬁdes
de novo. Though QSOX thus encompasses the functions of both
Ero1 and PDI, its sulfhydryl oxidase domain is not related to Ero1
but rather to a distinct enzyme family found primarily in mito-
chondria [14] and in the cytosol of certain virally infected cells
[15]. This family is known as the Erv sulfhydryl oxidases because
the yeast mitochondrial version is essential for respiration and
viability.
The ﬁrst QSOX enzyme studied in depth biochemically, puriﬁed
from chicken eggs [16–18], was shown by size exclusion chroma-
tography to be dimeric [16]. As all Erv enzymes studied to date
are also dimers [19–22], it was reasonable to hypothesize that
QSOX enzymes might all be dimers that self-associate through
their Erv-like domains. However, a recent study of recombinant
human QSOX1 (HsQSOX1) [23] conﬁrmed earlier experiments onlsevier B.V. All rights reserved.
Fig. 1. Schematic diagram illustrating the domain composition of QSOX compared to the Ero1/PDI pair, which catalyze the introduction of disulﬁde bonds into proteins in the
endoplasmic reticulum. Sulfhydryl oxidase domains and a description of their function are in blue. Thioredoxin fold domains are shown in pink, with the catalytically active
subset in a darker shade. The lettering on the PDI domains is the standard nomenclature for thioredoxin fold domains within this enzyme. The question mark in QSOX
corresponds to the helix-rich region (HRR). Redox-active disulﬁdes are illustrated as pairs of yellow balls; other disulﬁdes in the proteins are omitted from this presentation.
The QSOX transmembrane region is shown as a grey box, with the jagged line indicating that alternative splicing yields a version without the transmembrane segment. Gray
arrows show the proposed two-electron transfer steps involved in catalyzing disulﬁde bond formation and transfer in the QSOX and Ero1/PDI systems. The relative extent to
which the a and a0 domains of PDI serve as physiological electron donors to Ero1 may differ in different organisms.
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malian QSOX to be monomeric. This ﬁnding raised questions
regarding the pathway for electron transport within the enzyme
[23]. Clearly, a greater understanding of the domain organization
of QSOX, and the relative positions of its redox-active sites, would
facilitate interpretation of biochemical experiments and the design
of studies to probe the physiological roles and substrates of this
complex disulﬁde-generating catalyst. We present here the ﬁrst
structural study of a QSOX enzyme. Crystallization of a HsQSOX1
fragment containing the sulfhydryl oxidase active site resolves
the apparent contradiction between dimerization of single-domain
Erv enzymes and the monomeric state of mammalian QSOX.
2. Materials and methods
2.1. Vector construction and protein expression
The region of the human QSOX1 gene encoding amino acids 33–
546 was introduced into the pET-15b vector (Novagen) between
the Nde I and Bam HI restriction sites. The segment between the
Nco I and Nde I sites of the resulting construct was replaced using
synthetic oligonucleotides to eliminate the thrombin cleavage site
and incorporate a His6 tag fused directly to the protein. The se-
quence AAAENLYFQSAAA, including A TEV protease cleavage site
(underlined), was inserted in place of the original sequence EAA
at positions 272–274. The replacement was accomplished by
mutation to introduce a Not I restriction site, followed by cleavage
at the Not I site and ligation of synthetic oligonucleotides encoding
the desired sequence. Although a carboxy-terminal fragment of
HsQSOX could also be expressed directly, material derived from
protease cleavage of the larger HsQSOX construct yielded the crys-
tals used for data collection.
2.2. Protein expression and puriﬁcation
The recombinant QSOX construct HsQSOX133–546 including the
inserted TEV cleavage site was expressed in the Escherichia coli
strain BL21 (DE3) plysS (Novagen). Cells were grown in LB contain-
ing 100 mg/l ampicillin and 30 mg/l chloramphenicol to an
OD600 nm of 0.5–0.6 at 37 C. Isopropyl-1-thio-b-D-galactopyrano-
side was added to a ﬁnal concentration of 0.5 mM, and the cultures
were grown for a further 36 h at 15 C. Cells were harvested and
suspended in 20 mM sodium phosphate buffer, 500 mM NaCl,
and 20 mM imidazole (pH 7.4), sonicated on ice, and centrifuged
for 1 h at 40 000g. The supernatant was applied to a 5 ml Ni-NTA column using an AKTA FPLC (both from GE Healthcare), and
protein was eluted in 20 mM sodium phosphate buffer, 500 mM
NaCl, and a gradient of imidazole (20–500 mM) (pH 7.4). Eluted
protein was dialyzed overnight into 20 mM sodium phosphate buf-
fer, 200 mM NaCl (pH 7.4). TEV protease was expressed from a
plasmid provided by David Waugh (National Cancer Institute)
and puriﬁed using Ni-NTA chromatography. TEV cleavage of
HsQSOX133–546 was performed at room temperature for 6 h. Fol-
lowing cleavage, protein solution was again applied to a Ni-NTA
column. The HsQSOX1273–546 fragment did not bind the column
and was collected and dialyzed against 20 mM Tris, 200 mM NaCl
(pH 8.0). Limited proteolysis at a concentration of 0.5 mg/ml
HsQSOX1273–546 was performed for 1 hr at room temperature using
a 1:250 w/w ratio of trypsin:QSOX. Cleavage was terminated by
addition of phenylmethanesulfonyl ﬂuoride to a concentration of
1 mM. MALDI-TOF mass spectrometry of the resulting material
yielded a mass of 29 742 Da. The calculated mass of HsQSOX1286–546
is 29 741.4 after subtraction of 6 Da due to three disulﬁdes, consis-
tent with HsQSOX1286–546 being the product of trypsin digestion.
HsQSOX1286–546 was subjected to gel ﬁltration, and peak fractions
were pooled and concentrated to 25 mg/ml. The selenomethionine
variant was expressed according to published protocol [25] and
processed as described for wild-type HsQSOX1286–546.2.3. Crystallization, data collection, and structure reﬁnement
Crystals of HsQSOX1286–546 in space group P6422 were grown by
hanging drop vapor diffusion over well solution containing
100 mM citric acid (pH 5.3–5.6) and 12–16% (w/v) PEG 8000.
Microseeding into the same conditions gave larger crystals. Adding
10–15% ethanol to the well solution occasionally yielded crystals of
space group C222. Crystals were transferred to a 1:1 mixture of
Paratone oil (Exxon) and mineral oil before ﬂash-freezing. Data
were collected from a C222 crystal at 100 K on a RU-H3R generator
(Rigaku, Tokyo) equipped with a RaxisIV image plate and Osmic
mirrors. MAD data were collected from a P6422 crystal at the ID-
29 beamline at the European Synchrotron Radiation Facility (ESRF),
Grenoble, France. Data were processed and scaled using DENZO
and SCALEPACK [26]. Heavy atom site identiﬁcation and phasing
were performed using PHENIX [27], and an initial model was built
using Coot [28]. PHASER [29] was then used to solve the C222 crys-
tals by molecular replacement. Structure models were reﬁned
using CNS [30]. Data collection and reﬁnement statistics are re-
ported in Table 1.
Table 1
Crystallographic and reﬁnement statistics.
Space group P6422 native P6422 Semet peak P6422 Semet remote P6422 Semet inﬂection C222 native
Unit cell parameters (Å) 85.61  85.61  125.71;
a = b = 90,
c = 120
85.65  85.65  125.76;
a = b = 90,
c = 120
85.69  85.69  125.84;
a = b = 90,
c = 120
85.68  85.68  125.80;
a = b = 90,
c = 120
83.48  161.57  121.94;
a = b = c = 90
Resolutiona (Å) 50–2.05 (2.12–2.05) 50–2.0 (2.03–2.00) 50–2.0 (2.03–2.00) 50–2.0 (2.03–2.00) 50–2.0 (2.07–2.00)
Completeness (%) 99.8 (98.1) 96.2 (98.5) 95.9 (98.1) 96.2 (98.4) 98.8 (100)
Redundancy 16.0 (11.3) 11.8 (12.2) 11.9 (12.2) 11.9 (12.1) 5.9 (5.8)
Rsym
b 0.056 (0.737) 0.079 (0.867) 0.074 (0.562) 0.084 (0.968) 0.065 (0.553)
Rp.i.m
c 0.014 (0.189) 0.026 (0.255) 0.024 (0.313) 0.026 (0.286)
hI/rIi 16.4 (2.6) 11.0 (4.0) 12.5 (3.2) 10.9 (3.4) 12.6 (2.9)
Number of heavy atom sites 3
Figure of merit for phasing (to 2.0 Å) 0.458 (0.631 after density modiﬁcation)
Reﬁnement statistics P6422 C222
Protein molecules per asymmetric unit 1 3
Total reﬂections/test set 17681/1207 55254/3928
Rwork/Rfreed 0.275/0.324 0.237/0.271
Rms deviations from ideality
Bonds (Å) 0.011 0.007
Angles () 1.725 2.184
Number of atoms
Protein 2023 5853
Water 103 452
FAD 53 159
Citrate – 13
a Numbers in parentheses are for the highest resolution bin.
b Rsym = RhklRi|Ii(hkl)  hI(hkl)i|/RhklRiIi(hkl), where Ii(hkl) is the observed intensity and hI(hkl)i is the average intensity for i observations.
c Rp.i.m. = Rhkl[1/(N  1)]1/2Ri|Ii(hkl)  hI(hkl)i|/RhklRiIi(hkl) as described for the precision-indicating merging R factor [33]. Values were calculated using the program
RMERGE (available at http://www.embl-hamburg.de/~msweiss/projects/msw_qual.html).
d Rwork, Rfree = R||Fobs|  |Fcalc||/R|Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, respectively. A set of reﬂections (6.8% for P6422 and 7.1% for
C222) were excluded from reﬁnement and used to calculate Rfree.
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3.1. Expression of the sulfhydryl oxidase fragment of HsQSOX1
The folds of three HsQSOX1 domains can be classiﬁed by amino
acid sequence analyses (Fig. 1). The amino-terminal domain shows
30–35% sequence identity to various PDI familymembers. The second
domain of HsQSOX1, though highly diverged and lacking a Cys-X-X-
Cys redox-active motif, is identiﬁed by fold-recognition algorithms
as a thioredoxin superfamily domain (not shown). The third recog-
nizable HsQSOX1 domain, toward the carboxy-terminus, is related
to the Erv family of ﬂavin adenine dinucleotide (FAD)-dependent
sulfhydryl oxidases and contains conserved motifs involved in
FAD binding and disulﬁde formation [31]. The remaining region of
HsQSOX1, between the catalytically inactive thioredoxin fold do-
main and the Erv family module (question mark in Fig. 1), is pre-
dicted to have high helix content, but this helix-rich region (HRR)
does not show sequence similarity with any other known protein.
The unique modiﬁcation of a PDI family member by fusion to a
catalyst of de novo disulﬁde formation motivates an investigation
into the manner in which the HsQSOX1 domains interact to coordi-
nate disulﬁde formation and transfer. To determine the context of
the disulﬁde-generating module within the multi-domain
HsQSOX1 structure, we isolated and crystallized a HsQSOX1 frag-
ment spanning the HRR and Erv regions. HsQSOX1, like chicken
QSOX [13], has a protease-sensitive region immediately
downstream of the redox-inactive thioredoxin fold domain. Into
this region we inserted a TEV protease site to facilitate speciﬁc
cleavage and isolation of the carboxy-terminal HsQSOX1 fragment.
Additional proteolytic trimming resulted in a fragment named
HsQSOX1286–546 according to its amino acid boundaries.
3.2. Structure of the HsQSOX1286–546 Erv domain
The structure of the HsQSOX fragment containing the sulfhydryl
oxidase domain was determined by X-ray crystallography to 2.0 Åresolution and is presented in Fig. 2A, in comparison with a single-
domain Erv family protein. Independent copies of HsQSOX1286–546
showed similar conformations (Fig. 2B), with a largest pair-wise
root-mean-square deviation for Ca positions of 0.6 Å for all four
molecules in the two crystal forms. As predicted, the Erv domain
of HsQSOX1 shares the same fold as single-domain members of
the family (Fig. 2A) and binds FAD similarly at the mouth of a
slightly funnel-shaped four-helix bundle (Fig. 2C).
One signiﬁcant difference between the QSOX FAD binding do-
main and previously determined Erv family structures is that the
active site within the HsQSOX1286–546 fragment appears to be ste-
rically more accessible (Fig. 2C). Helix a1 of other Erv proteins are a
turn or two longer at their amino-termini than helix a1 of
HsQSOX1286–546. The region just amino-terminal to helix a1 in
HsQSOX consists of the disulﬁde-bonded loop between Cys393
and Cys405, and this loop is more distant from the active-site cys-
teines than are the amino-terminal ends of typical Erv a1 helices.
HsQSOX1286–546 lacks the basic residue that projects in other Erv
enzymes from helix a1 into the vicinity of the active-site disulﬁde
(Fig. 2C) and is presumably important in stabilizing the reduced,
thiolate form of an active-site cysteine [31].
The FAD binding domain of QSOX further differs from other Erv
enzymes in the locations of non-active-site disulﬁde bonds. First, a
CX16C structural disulﬁde linking helix a4 with the following loop
in mitochondrial Erv enzymes is absent in QSOX (Fig. 2A). Second,
sequence alignments would suggest that the most carboxy-termi-
nal QSOX disulﬁde, a highly conserved CXXC motif, corresponds to
the Erv ‘‘shuttle” disulﬁde, which mediates transfer of electrons
from substrate to the FAD-proximal, active-site cysteines [19].
However, there is a discrepancy of 20 Å in the positions of the
QSOX CXXC and Erv shuttle cysteines in structure superpositions.
Due to two extra HsQSOX1 loops with no counterparts in other
Erv enzymes, the QSOX disulﬁde in question is located amino-ter-
minal rather than carboxy-terminal to helix a5 (Fig. 2A). These two
extra HsQSOX1 loops are the 10 residue segment (residues 490–
500) immediately downstream of helix a4 and a 20 residue loop
Fig. 2. Structure of HsQSOX286-546 and comparison with a single-domain Erv enzyme. (A) Left, disulﬁde motifs (shown as balls-and-sticks) and the helices in the FAD binding
domain are labeled on a ribbon diagram of HsQSOX286–546 (molecule C from the C222 structure). FAD is represented in orange sticks. The central panel shows the view
obtained by rotating 45 around the horizontal axis. The structure of yeast Erv2p (PDB ID code 1JR8) [19] is shown on the right for comparison. The FAD binding domains of
HsQSOX and Erv2p are very similar, and the HRR of QSOX appears to be a degenerate Erv sulfhydryl oxidase domain that packs against the active domain with similar
geometry as seen in the Erv family dimers. An interesting helical turn containing an extra residue (4.5 instead of the canonical 3.6) in the HRR is labeled with a white
asterisk (). (B) Ca traces of the multiple copies of HsQSOX286–546 in the C222 crystals (molecules A–C) are superposed and colored according to B factor (high = red,
low = blue). The region of the active-site, including the isoalloxazine of the FAD, has relatively high mobility within the crystals. (C) The active-site regions of HsQSOX286–546
and yeast Erv2p are shown. Amino acid side chains in stick representation contribute to the hydrophobic pocket in which the FAD isoalloxazine binds. Sulfurs in the active-
site disulﬁdes are shown as spheres at half their van der Waals radii. Helix a1 of Erv2p is semi-transparent so that the FAD isoalloxazine and the tryptophan residue against
which it packs can be seen below it. The lysine side chain that points into the active-site of Erv2p and other Erv family sulfhydryl oxidases (but is not seen in the HsQSOX286–546
fragment) is shown in the center of the Erv2p image.
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upstream of helix a5 (Fig. 2A).3.3. Structure of the QSOX helix-rich region
The HRR forms a compact four-helix bundle domain. When
we superposed HsQSOX1286–546 on other Erv family domains,
we observed a remarkable correspondence between the helices
of QSOX HRR and the second subunit of the Erv dimer
(Fig. 2A, compare yellow/orange/red helical domains in central
and right ribbon diagrams). Automated structure comparison
[32] conﬁrmed the similarity, listing an Erv family protein as
the highest structural match to the HRR (Z score 6.0), after a
de novo designed di-iron protein (Z score 6.2). Despite the sim-
ilarity of the HRR to Erv domains in helix topology, the HRR
lacks active-site cysteines as well as the residues that form the
FAD binding motif of Erv enzymes [31]. Furthermore, the interh-
elical packing angles do not precisely match those of functional
Erv domains. Other high-scoring structural matches to the HRR
were hemerythrin (Z score 5.5) and cytochrome c0 (Z score
4.4), which, like the designed di-iron protein, bind other cofac-
tors and not FAD.
4. Discussion
The carboxy-terminal portion of HsQSOX1, comprising the sulf-
hydryl oxidase active site, appears to be a product of domain dupli-
cation and fusion. The result is a pseudo-dimeric structure with
remarkable similarity to the true dimers of Erv sulfhydryl oxidaseenzymes. Only one of the ‘‘subunits” of the HsQSOX1 pseudo-di-
mer has retained activity as a sulfhydryl oxidase, however, and
even this module depends for efﬁcient catalysis on the presence
of a functional PDI-like oxidoreductase domain at the QSOX amino
terminus [13,23]. The redox-active disulﬁde in the QSOX amino-
terminal domain may serve as the direct electron donor to the
FAD-proximal cysteines, as illustrated in Fig. 1. It will be interest-
ing to ﬁnd out if the QSOX PDI-like domain also supplies the miss-
ing basic residue to stabilize an active-site thiolate in the Erv
domain during catalysis.
Single-domain Erv sulfhydryl oxidases lack a PDI-like domain
and thus naturally resemble the QSOX fragment structure pre-
sented herein (Fig. 2A). Like QSOX, though, many Erv enzymes also
require multiple disulﬁdes for catalysis. In addition to the
FAD-proximal disulﬁde, Erv enzymes often contain, near one of
the termini, an additional, ‘‘shuttle” disulﬁde in a CX1–4C motif that
transfers electrons from substrate to the active site. The CXXC mo-
tif near the carboxy-terminus of QSOX was a candidate for such a
role, but the HsQSOX1286–546 structure shows this disulﬁde to be
on the opposite side of the protein, 27 Å through the protein core
and a greater distance circumferentially from the active site. Fur-
thermore, this disulﬁde is functionally dispensable for QSOX oxida-
tion of small molecule and model protein substrates in vitro [23].
Whether this conserved CXXC disulﬁde is redox-active in another
capacity or has a structural role in QSOX enzymes remains to be
determined, but it is not likely to serve as a shuttle to the active-
site cysteines in a manner directly analogous to the single-domain
Erv family proteins.
The HsQSOX1 HRR, which shows structural similarity both to
the Erv family and to primitive oxygen and electron carrying
A. Alon et al. / FEBS Letters 584 (2010) 1521–1525 1525proteins such as hemerythrins and four-helix bundle cytochromes,
underscores the versatility of this simple fold. It is interesting to
note that hemerythrins coordinate two iron atoms using a series
of amino acid side chains including ﬁve histidines. Histidines are
also used to ligate heme in cytochromes. The consensus sequence
for FAD binding by Erv domains contains a core di-histidine motif
[31]. Though highly speculative, Erv enzymes, including QSOX,
may share common origins with primordial metal-binding
proteins.
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